CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.

MLA

Dongzheng Gai, et al. “CST6 Suppresses Osteolytic Bone Disease in Multiple Myeloma by Blocking Osteoclast Differentiation.” Journal of Clinical Investigation, vol. 132, no. 18, Sept. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1172/JCI159527.

APA

Dongzheng Gai, Jin-Ran Chen, Stewart, J. P., Intawat Nookaew, Habelhah, H., Ashby, C., Fumou Sun, Yan Cheng, Can Li, Hongwei Xu, Bailu Peng, Garg, T. K., Schinke, C., Thanendrarajan, S., Zangari, M., Fangping Chen, Barlogie, B., van Rhee, F., Tricot, G., & Shaughnessy Jr., J. D. (2022). CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation. Journal of Clinical Investigation, 132(18), 1–15. https://doi.org/10.1172/JCI159527

Chicago

Dongzheng Gai, Jin-Ran Chen, James P. Stewart, Intawat Nookaew, Hasem Habelhah, Cody Ashby, Fumou Sun, et al. 2022. “CST6 Suppresses Osteolytic Bone Disease in Multiple Myeloma by Blocking Osteoclast Differentiation.” Journal of Clinical Investigation 132 (18): 1–15. doi:10.1172/JCI159527.